Synageva Biopharma Corp has a market cap of $1 billion; its shares were traded at around $49.72 with and P/S ratio of 476.9.
This is the insider trade history vs. stock price of GEVA. For the complete insider trading history of GEVA, click here.
Directors and Officers Recent Trades:
- Director, 10% Owner Julian Baker bought 886,000 shares of GEVA stock on 07/13/2012 at the average price of 41.2. Julian Baker owns at least 1,737,085 shares after this. The price of the stock has increased by 20.68% since.
- Director, 10% Owner Felix Baker bought 886,000 shares of GEVA stock on 07/13/2012 at the average price of 41.2. Felix Baker owns at least 1,736,565 shares after this. The price of the stock has increased by 20.68% since.
- Director Thomas J Tisch bought 73,000 shares of GEVA stock on 07/12/2012 at the average price of 41.2. Thomas J Tisch owns at least 730,956 shares after this. The price of the stock has increased by 20.68% since.
- 10% Owner Daniel R Tisch sold 29,200 shares of GEVA stock on 07/12/2012 at the average price of 46.75. Daniel R Tisch owns at least 399,019 shares after this. The price of the stock has increased by 6.35% since.
- 10% Owner Daniel R Tisch sold 10,000 shares of GEVA stock on 07/11/2012 at the average price of 45.73. Daniel R Tisch owns at least 428,219 shares after this. The price of the stock has increased by 8.73% since.
For the complete insider trading history of GEVA, click here.






RSS